1MD’s newest health supplement, Advanced Turmeric Curcumin X285, provides best-in-class systemic support with two clinically studied ingredients.
LOS ANGELES, CA, January 17, 2018 /24-7PressRelease/ — 1MD, leading supplement producer, announces today the launch of its Advanced Turmeric Curcumin X285. This new and improved formula contains two clinically studied ingredients at their clinical dose to relieve body and joint discomfort and promote optimal brain health.
1MD’s Advanced Turmeric Curcumin x285 formula combines two patented ingredients, Longvida Optimized Curcumin Extract and WokVel Extract, both clinically studied and shown to boost overall systemic health.
Longvida Optimized Curcumin uses a patented, clinically studied, solid lipid curcumin particle, which has been shown by researchers to deliver free curcumin directly to the targeted tissues that need it most, making it up to 285 times more absorbable than generic 95% curcumin.
Standardized to 40% boswellic acids in naturally occurring ratios, WokVel Extract preserves the natural spectrum of active boswellia compounds using a patented process that yields a highly bioavailable form of the botanical without altering its nutrient profile.
Board certified cardiologist and 1MD Medical Advisor, Dr. Michael Fenster certifies, “1MD has created the best turmeric curcumin product on the market and I recommend Advanced Turmeric Curcumin x285 to anyone looking to improve joint health, aid joint discomfort, elevate brain health, and boost energy levels and overall systemic relief in the body.”
1MD is a formulator of scientifically backed, clinically studied health supplements and publisher of health, wellness, and fitness-related content. Our mission is to help people make smarter health choices and lead healthier lifestyles by creating industry-leading products and cutting-edge health content. More information about 1MD is available at https://1md.org.
For the original version of this press release, please visit 24-7PressRelease.com here